Down-regulation of GRP78 is associated with the sensitivity of chemotherapy to VP-16 in small cell lung cancer NCI-H446 cells
<p>Abstract</p> <p>Background</p> <p>Chemotherapy resistance remains a major obstacle for the treatment of small cell lung cancer (SCLC). Glucose-regulated protein 78 (GRP78), an endoplasmic reticulum chaperone, plays a critical role in chemotherapy resistance in some c...
Main Authors: | Shao Shujuan, Wang Jiarui, Wang Siyan, Wang Wei, Wang Yingyan, Wang Qi |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2008-12-01
|
Series: | BMC Cancer |
Online Access: | http://www.biomedcentral.com/1471-2407/8/372 |
Similar Items
-
Down-regulation of GRP78 Enhances Chemotherapy Sensitivity to VP-16 in Lung Adenocarcinoma
by: Li JIANG, et al.
Published: (2009-11-01) -
The Role of GRP78 on the Resistance to Cisplatin in SPCA-1 Cell Line
by: Long ZHAO, et al.
Published: (2010-01-01) -
GRP78 in lung cancer
by: Shengkai Xia, et al.
Published: (2021-03-01) -
99mTc-octreotide Receptor Scintigraphy in NCI-H446 Small Cell Lung Cancer Nude Mice Model
by: Chao LI, et al.
Published: (2015-01-01) -
Apatinib Combined with CCI-779 Inhibits the Proliferation and Migration of Small Cell Lung Cancer NCI-H446 Cells In Vitro
by: Chao LIU, et al.
Published: (2020-04-01)